GENEVA, Sept. 24 -- HCW BIOLOGICS, INC. filed a patent application (US2026/011052) for “MESOTHELIN-SPECIFIC CHIMERIC T CELL ENGAGER POLYPEPTIDES”. With publication no. WO/2026/152120, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: C07K 16/46
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....